(Q44437963)

3 December 2017

title

Conversion to sirolimus in solid organ transplantation: a single-center experience (English)

1 reference

3 December 2017

Conversion to sirolimus in solid organ transplantation: a Single-Center experience (English)

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(03)00240-9

1 January 2024

main subject

organ transplantation

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(03)00240-9

1 January 2024

author name string

M. F. Egidi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742485

1 January 2024

P. A. Cowan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742485

1 January 2024

A. Naseer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742485

1 January 2024

A. O. Gaber

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742485

1 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

3 December 2017

https://api.elsevier.com/content/article/PII:S0041134503002409?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(03)00240-9

https://api.elsevier.com/content/article/PII:S0041134503002409?httpAccept=text/plain

1 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(03)00240-9

Transplantation Proceedings

1 January 2024

published in

1 reference

3 December 2017

volume

35

1 reference

3 December 2017

issue

3 Suppl

1 reference

3 December 2017

page(s)

131S-137S

1 reference

The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Improved graft survival after renal transplantation in the United States, 1988 to 1996

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Factors influencing kidney graft survival in Latin America. Collaborative Transplant Study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Four-year follow-up of the European Tacrolimus Multicenter Renal Study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Renal complications after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

CHRONIC RENAL FAILURE FOLLOWING LIVER TRANSPLANTATION

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

The importance of early prevention of renal dysfunction in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Call for revolution: a new approach to describing allograft deterioration

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Chronic allograft nephropathy: An update

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

ACCUMULATING MONOCYTES IN THE VASCULATURE OF RAT RENAL ALLOGRAFTS: PHENOTYPE, CYTOKINE, INDUCIBLE NO SYNTHASE, AND TISSUE FACTOR mRNA EXPRESSION1

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Haemolytic uraemic syndrome (HUS) during treatment with cyclosporin A after renal transplantation--is tacrolimus the answer?

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Post-transplant diabetes mellitus. The role of immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Rapamycin: clinical results and future opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Rapamune (Sirolimus, rapamycin): an overview and mechanism of action.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

A novel approach to the treatment of chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

The Banff 97 working classification of renal allograft pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas tran

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Withdrawal of steroids after renal transplantation--clinical predictors of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Withdrawal of steroid immunosuppression in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Outcomes of African-American kidney-transplant recipients treated with sirolimus, tacrolimus, and corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900240-9

7 January 2021

Identifiers

1 reference

3 December 2017

1 reference